Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors
about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaPylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaPylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaPancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinomaPylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaPancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinomaGenetic alterations in pancreatic carcinomaTherapeutic potential of targeting acinar cell reprogramming in pancreatic cancerInfluences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinomaEGF receptor is required for KRAS-induced pancreatic tumorigenesisAkt kinase mediates the prosurvival effect of smoking compounds in pancreatic ductal cells.TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth.Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.bax, but not bcl-2, influences the prognosis of human pancreatic cancerGroup II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis.Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.Advances in biomarker research for pancreatic cancer.Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cellsRole of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.Molecular prognostic factors in patients with pancreatic cancer.Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy.Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.Biologic instability of pancreatic cancer xenografts in the nude mouse.The novel Trk receptor tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness.99mTc-LHRH in tumor receptor imaging.Acinar-ductal-carcinoma sequence in transforming growth factor-alpha transgenic mice.Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.Growth factor receptor expression in human gastroenteropancreatic neuroendocrine tumours.Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.
P2860
Q21129230-DFDF625D-D0F2-4888-BB2B-17E438709D38Q24186132-7E91638A-6F13-42D0-B596-D514946C9A02Q24188034-049AEC17-E873-4671-8C2C-D351348E7AAAQ24234236-930D8C0B-F42F-4309-82B5-B499A6F272C9Q24234656-31714A64-E761-43A1-9BE4-21A2D46939D1Q24243112-04BAA0C2-B372-47BB-8F49-F8A04029DB6AQ24801465-0B763837-855B-4A59-8F77-8A0BDB79E972Q28068998-5E5A24F5-4F88-40E1-9B38-0DC2139D79EDQ28216866-B4D9C0CD-0CA0-4CDB-9AED-BE827C22A801Q28584901-8C6DD05D-8E25-486D-AD68-B7C3FEEBF6DCQ33856642-55F38D94-5B7F-41C9-AF93-B98E68581898Q33890489-6B80155B-A764-42B1-971E-25C62BE7BD01Q34642090-607DCCD1-7FD0-4F41-92F0-E1138D693AFFQ35352240-9B689E9C-C9D6-488B-A711-F1F2A87EC3D8Q35357077-17BEEF8B-C4C8-4202-9E82-D647295B3A8FQ36116282-70FC7904-D6B6-439B-A7B3-8ECF4DB411A3Q36126609-57110383-2357-4987-B256-92BD8F4EDD93Q36321055-504DCCEB-2277-4810-863B-EA7633CD056FQ36860627-AA2D2F47-2E3C-4246-AC35-99470DD038F7Q37004734-25A7C555-586A-425A-B042-FA70B58C0945Q37354440-A4528D60-394D-46D7-A148-0B5EBAADD6B7Q40679145-CBDBF8A0-C104-42E5-B007-91275B9EEA6DQ40871227-D154DED5-FCBD-4B09-9BF1-409085097036Q40876210-4D7EA530-BD5E-452B-818A-89DFBEF4BBEAQ40940403-8CD60850-910C-493F-8750-EB6EA2F54C99Q40979226-9DB8BB3A-1477-40E6-B897-AA1FF530B6CAQ42813026-ED4B4B9E-F621-4B70-A0B0-22AE9D105EB9Q44432238-FAD28BFC-743C-4442-A2FE-45C1555A29D3Q45151598-869E2CAA-D720-4883-8380-A6C0421783C7Q47705363-262EAD31-D878-4B55-9D6B-25CE623BA883Q50539676-52050573-DFAC-4CF4-B3E0-96D5A67EC9E0Q54601280-BB877D20-04EA-4E66-AC2F-47FC9993A765
P2860
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Pancreatic cancer: the potenti ...... th factors and their receptors
@ast
Pancreatic cancer: the potenti ...... th factors and their receptors
@en
Pancreatic cancer: the potenti ...... th factors and their receptors
@nl
type
label
Pancreatic cancer: the potenti ...... th factors and their receptors
@ast
Pancreatic cancer: the potenti ...... th factors and their receptors
@en
Pancreatic cancer: the potenti ...... th factors and their receptors
@nl
prefLabel
Pancreatic cancer: the potenti ...... th factors and their receptors
@ast
Pancreatic cancer: the potenti ...... th factors and their receptors
@en
Pancreatic cancer: the potenti ...... th factors and their receptors
@nl
P2093
P356
P1476
Pancreatic cancer: the potenti ...... th factors and their receptors
@en
P2093
P2888
P356
10.1007/BF00202070
P407
P577
1996-01-01T00:00:00Z
P6179
1001219838